Status:

COMPLETED

Immune Evidence to the Consumption of Lactobacillus GG and FOS Consumption in Patients With Herpes Labialis

Lead Sponsor:

Sprim Advanced Life Sciences

Conditions:

Herpes Labialis

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Herpes labialis (HL) is the result of the presence of a virus called HSV-1 and is a common disease. Because of its visibility due to cold sores it has a serious impact on social life. Until now there ...

Detailed Description

Background: Herpes labialis is the result of the presence of HSV-1 and is a common disease. Because of its visibility it has a serious impact on social life. Until now there is no effective treatment ...

Eligibility Criteria

Inclusion

  • Healthy free-living men and women aged 18 to 65 years-old.
  • History of recurrent HL (2 - 4 episodes) after exposure to sunlight in the previous 12 months.
  • Fitzpatrick skin type 1 to 4 (appendix 1 of the study protocol).
  • No presence of HL lesions at time of recruitment, including baseline.
  • Agreement to adhere to the prescribed list of dietary recommendations provided at the start of the study (appendix 3 of the study protocol).
  • Women of child-bearing potential are required to use adequate birth protection during the study.
  • Sign and date the ICF to and to comply with study procedures

Exclusion

  • Presence of acute/terminal disease.
  • Intolerance for milk protein or lactose.
  • Treatment with acyclovir or other medication believed to interfere with immune responses at the time of the study.
  • Participation in any herpes UV reactivation study within the previous three months.
  • Pregnancy or lactation.
  • Any condition (e.g. schizophrenia, psychosis, major depression or mental deficiency) or major co-morbidity that the study investigator thinks might compromise the person's ability to comply with the requirements of the study.

Key Trial Info

Start Date :

September 14 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2011

Estimated Enrollment :

157 Patients enrolled

Trial Details

Trial ID

NCT03310294

Start Date

September 14 2010

End Date

August 1 2011

Last Update

October 16 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.